Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 2

1(12.5%)

8Total

N/A(7)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07402382Not ApplicableRecruiting

Effects of Amylopectin Chromium Blend on Whole-Body Protein Kinetics and Glucose in Peri/Post-Menopausal Women

Role: lead

NCT04828278Not ApplicableCompleted

Nutrition21 Study 1

Role: collaborator

NCT06010745Not ApplicableUnknown

Effectiveness of a Novel Dietary Ingredient on Hair Growth and Skin's Appearance

Role: lead

NCT00477854Not ApplicableCompleted

Effects of Chromium Picolinate on Food Intake

Role: collaborator

NCT00759993Phase 2Terminated

Chromium Piccolinate in the Prevention of Weight Gain Induced by Serotonergic Medications Initiated on Psychiatric Inpatient Units.

Role: collaborator

NCT01464814Not ApplicableUnknown

Clinical Trial Evaluating the Viability of L. Casei + Fish Oil Capsules

Role: lead

NCT00308451Not ApplicableCompleted

A 30 Day Acute Efficacy and Safety Study of Chromium Picolinate + Biotin on Glycemic Control in Overweight or Obese Subjects With T2DM

Role: lead

NCT00289354Not ApplicableCompleted

Efficacy and Safety Study of Chromium Picolinate + Biotin on Glucose and Cholesterol Control in T2DM

Role: lead

All 8 trials loaded